Trisomy 13, also known as Patau syndrome, is a widely congenital anomaly syndrome characterized by microphthalmia, cleft lip, and palate, microcephaly with a sloping forehead, congenital heart disease, and polydactyly of the limbs. Patau syndrome is identified either prenatally or postnatally. Its survival rate is low, and most of the patients die even before their first year of life. The risk of trisomy 13 is higher in women of advanced maternal age. Brain and cardiovascular abnormalities are typically the primary factors contributing to the syndrome's poor prognosis. We report a case of a male newborn born at full term from a first-degree consanguineous marriage. Upon initial inspection, the patient had classic dysmorphic features, including low-set ears, a cleft lip and palate, a short neck, bilateral anophthalmia, and polydactyly of the limbs. After chromosomal analysis, the diagnosis was made, and a trisomy 13 was discovered.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11170545 | PMC |
| http://dx.doi.org/10.7759/cureus.60264 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Accuracy of cell-free fetal DNA in detecting chromosomal anomalies in women experiencing miscarriage: systematic review and meta-analysis.
Ultrasound Obstet Gynecol
January 2025
Center for Fetal Care and High-Risk Pregnancy, University of Chieti, Chieti, Italy.
Objective: To report the diagnostic accuracy of cell-free fetal DNA (cfDNA) in detecting fetal chromosomal anomalies in women experiencing miscarriage.
Methods: PubMed, MEDLINE, EMBASE and Cochrane databases were searched from inception to June 2024. The inclusion criteria were women experiencing miscarriage (defined as pregnancy loss before 20 weeks of gestation) who underwent cfDNA screening for trisomies 21, 18 and 13, other autosomal aneuploidies, sex-chromosome aneuploidies and/or copy-number variants (CNVs).
Opioid-Free Anesthesia for a Child With Patau Syndrome With External Oblique Intercostal Fascial Plane Blocks.
Paediatr Anaesth
December 2024
Department of Anaesthesiology and Intensive Care, Children's Health Ireland at Crumlin, Dublin, Ireland.
Massive parallel sequencing-based non-invasive prenatal test (NIPT) identifies aberrations on chromosome 13.
Eur J Obstet Gynecol Reprod Biol
November 2024
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden; Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden. Electronic address:
Article Synopsis
- * A total of 4,532 NIPT tests were performed, with 125 indicating an increased risk for trisomies 13, 18, 21, and sex chromosome abnormalities; further testing revealed other chromosomal issues not covered by standard NIPT.
- * The findings showcase the ability of NIPT to detect complex chromosomal abnormalities, such as segmental duplications and mosaicism, underscoring its potential for genome-wide screening of copy number variations. *
Trisomy 13, home health-care and multidisciplinary approach: Case report.
Rev Paul Pediatr
October 2024
Faculdade Ciências Médicas de Minas Gerais, Post-Graduate Program in Health Sciences, Belo Horizonte, MG, Brazil.
Article Synopsis
- The objective of the text is to highlight the importance of recognizing and addressing Patau's syndrome through a case study of a 2-year-old patient receiving extensive Home Care services.
- The case describes a female patient who underwent a cesarean delivery due to restricted growth and was diagnosed with Patau's syndrome at birth, yet has survived longer than expected with specialized home-based care.
- The comments emphasize that a multidisciplinary care approach, including medical and psychological support, has led to positive outcomes and stresses the importance of support networks for families dealing with similar illnesses.*
Amniotic fluid glucose concentration as a predictor of fetal trisomy.
J Obstet Gynaecol Res
November 2024
Division of Obstetrics and Gynaecology, Department of Reproductive and Developmental Medicine, Akita University Graduate School of Medicine, Akita, Japan.
Aim: We aimed to assess the amniotic fluid glucose concentration cut-off as an indicator of fetal chromosomal abnormalities, such as trisomy 13, 18, and 21.
Methods: This prospective observational study included pregnant females who underwent amniocentesis. Participants were divided into two groups on the border of 22 weeks of gestational age (<22 and ≥22-week groups).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!